Monte Rosa Therapeutics
GLUE
GLUE
53 hedge funds and large institutions have $742M invested in Monte Rosa Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 56 → 53 (-3)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
53
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$20.4M | |
| 2 | +$5.82M | |
| 3 | +$4.77M | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$1.91M |
| 5 |
E
Ergoteles
New York
|
+$1.52M |
Top Sellers
| 1 | -$3.91M | |
| 2 | -$2.67M | |
| 3 | -$2.04M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.76M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$1.11M |